Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy.

Cancers·2026
Same author

The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival.

Biomolecules·2026
Same author

Prognostic impact of TROP2 in adenocarcinoma of the esophageal junction and stomach.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

MACC1 Expression in Colorectal Cancer Is Upregulated by Loss of Epigenetic Repression Under Oxidative Stress Condition.

Cell biochemistry and function·2025
Same author

Novel High-Throughput Screen Identified S100A4 Inhibitors for Anti-Metastatic Therapy.

International journal of biological sciences·2025
Same author

TransTACs: novel heterobispecific antibodies for targeted protein degradation in cancer therapy.

Signal transduction and targeted therapy·2024

Related Experiment Video

Updated: May 10, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

MACC1 - a novel target for solid cancers.

Ulrike Stein1

  • 1Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück-Center for Molecular Medicine, Berlin , Germany. ustein@mdc-berlin.de

Expert Opinion on Therapeutic Targets
|July 3, 2013
PubMed
Summary

Metastasis-associated in colon cancer 1 (MACC1) is a key gene predicting colorectal cancer metastasis and patient survival. MACC1 shows promise as a biomarker and therapeutic target for various solid cancers.

More Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
11:01

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Published on: August 24, 2021

Related Experiment Videos

Last Updated: May 10, 2026

In Vitro Assay to Study Tumor-macrophage Interaction
08:36

In Vitro Assay to Study Tumor-macrophage Interaction

Published on: August 1, 2019

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes
11:01

Automated Imaging and Analysis for the Quantification of Fluorescently Labeled Macropinosomes

Published on: August 24, 2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Metastatic dissemination significantly impacts patient survival across numerous cancer types.
  • The gene metastasis-associated in colon cancer 1 (MACC1) was identified in colorectal cancer (CRC) tissues.
  • MACC1 serves as a tumor stage-independent predictor of CRC metastasis and metastasis-free survival.

Purpose of the Study:

  • To review the discovery and validation of MACC1 as a biomarker.
  • To explore MACC1's predictive value for prognosis and therapy response in CRC and other solid cancers.
  • To envision the clinical utility of MACC1 as a therapeutic target for metastasis restriction.

Main Methods:

  • Review of existing literature on MACC1 discovery and validation.
  • Analysis of MACC1's correlation with tumor progression, metastasis, and patient survival.
  • Assessment of MACC1's predictive value for therapy response.

Main Results:

  • MACC1 has been extensively validated as a prognostic biomarker in various solid cancers.
  • MACC1 correlates with tumor formation, progression, metastasis development, and patient survival.
  • MACC1 demonstrates predictive value for therapy response.

Conclusions:

  • MACC1 is a significant driver of tumorigenesis and metastasis.
  • MACC1 is a promising therapeutic target for anti-tumor and anti-metastatic interventions.
  • Further clinical trials are necessary to confirm MACC1's clinical utility.